{"name":"Vima Therapeutics","slug":"vima-therapeutics","ticker":"","exchange":"","domain":"vima.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNdGVUdHIzS0RCMG5pVjZELWJjZVRLQk9WVm8zN0F1LWNMaWRhUFdoeWw5cUFzMjVjbW5ZemRmb2JmMlF4UVJMbndYNmFmMEMxWUJUZWhOZFVKRWVUdFJpa3lya1JrTTgtMFdQNXFoQXBZakc1R2ZVT0tTcFNINmxMMXdiNFZmNmRmc3c?oc=5","date":"2026-03-20","type":"pipeline","source":"pharmaphorum","summary":"Kidney biotech R1's $78m debut, and other biofinancings - pharmaphorum","headline":"Kidney biotech R1's $78m debut, and other biofinancings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNRGR5N1dCNF9PMGJLM2xKNTUtMFEzb3lfcGRNTjFSd2NrRzBkMjRxNWZrdUlPay1QYm1RcGRBRmdxd3BnQjM2UUFXcHJNbFVKQ2pzTW12U2loMDlOSDJoVWY1ZVEzeExEbkhCazdRSzJIYWJKb1BSU0poSHF2TXA1SmdBVE9GXzd5eFBOTndNb1dpUzhuRktSM2Npc3h5RHBHN2ozNFNTZ3ZxTkZjMDdwaVJR?oc=5","date":"2026-03-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Vima banks $100m in Series A to progress Parkinson’s drug - Pharmaceutical Technology","headline":"Vima banks $100m in Series A to progress Parkinson’s drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOVWlLQzloelB5aldOU3Mtem9GTWtlN1JRczA2MUhOdlNpNHktU0ZwVWRSdDFNZVVJUXpyTEstMlIwRkpabnlYMTB2NWJYRUlWQjBUVElpdUdPOVFCQTJ4aWVtUHFkWEhwLVFEVERHenZrNW5jWGE4T2VjclM4S1FJX0JJR281MG5GLTJQajAtS1dDTXhBOV9sY3NGc0M1Z3VFdF93ZXd4M1hkSzdhUklSSw?oc=5","date":"2026-03-11","type":"pipeline","source":"BioPharma Dive","summary":"With $100M, Vima pursues an oral drug for movement disorders - BioPharma Dive","headline":"With $100M, Vima pursues an oral drug for movement disorders","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-11","type":"pipeline","source":"GlobeNewswire","summary":"Vima Therapeutics Announces First Dystonia Patient Dosed in - GlobeNewswire","headline":"Vima Therapeutics Announces First Dystonia Patient Dosed in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQS2ZjdUk0NlQza2hvT1hOQjRsTURjb3ZGQVFVcWhoRG5kVWZkaXlkLXBGY3pnRkg1SXJrdzRrNDdyN0hDanZTN0lMR2E3N0RWV2tPdXNlcnpxU0MyRUlpX1BxWUtXSmVQa05CdUVXRXhlYlpjanZpSTZxNm5uVElVc0lFYnZWUk9QTmFrekh6LVVSZm02R0lIbkx1b1JfNnpvOHBRWg?oc=5","date":"2025-05-30","type":"pipeline","source":"The Pharma Letter","summary":"Vima Therapeutics debuts with $60 million financing - The Pharma Letter","headline":"Vima Therapeutics debuts with $60 million financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNUnhZMFNBUWJRVVZVM3hVeWJ1VWFVT0hITDVYeHNZSG5OWkp5OHVWVlUtb0FFVVVFS1BlVXRwN1JLb2FMMm5aRUxaaS1PUVdGd25TR3BpOTlWeTZvMktiUmRVLVJvMjB3M2otcDJxcWhyMWhOV2tvQm5aX2JmTE1yT1hueHFsal9zcm9ZZWV3?oc=5","date":"2025-05-30","type":"pipeline","source":"FinSMEs","summary":"Vima Therapeutics Raises $60M in Series A Funding - FinSMEs","headline":"Vima Therapeutics Raises $60M in Series A Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNU2xWWDlia1ptemxwNXo4ZDJrTW50NkpMUjZ5RXlWOUhKVUI4U3N4MjFRVHdSWVFqcWZvZkV2cTRBdFBBOHVGSnI0cHVLZVpqcmhGVlRJeF9mS1VHcGltOGk0SEM2M2NXQWtQX0dTeXFPbF95VEQ2aU5HZ0t4WllyUjlVQzBYUTR2?oc=5","date":"2025-05-30","type":"pipeline","source":"pharmaphorum","summary":"GRIN raises $140m for epilepsy drug, and other financings - pharmaphorum","headline":"GRIN raises $140m for epilepsy drug, and other financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5CMzFKdmtFTFRTSXFDQ3NiUzlUVzY0TlUzSDRCSEgxd1pYNUMwYVdFcFJyS2JtUE03TmRRNGFFdENiclRXRm9PdVBYUHZfQnVNSE9N?oc=5","date":"2025-05-29","type":"pipeline","source":"FirstWord Pharma","summary":"Vima clinches $60M to move oral dystonia candidate into mid-stage testing - FirstWord Pharma","headline":"Vima clinches $60M to move oral dystonia candidate into mid-stage testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOMHdaN0RyUUFlTXk3MUpJMElFbFRPOUJiZVktUUFlNVliMTFVUk9UUXFjTnhBUncyNUcwUE5wc2JKbmhOZS0xemJ5MEVyWk9VWlVSaTVqYnl0Smp1M0ZkRmxVRDhYMUhkdDVuUUMtV0JUdDY1Rm5mdkJmX0tSRjFRb0VjMnR6bVJBSGhxOHRVS0RGOU5WSW51U1F5cHFpQUhPZFF0Ym9nbGEzdkxnODlDdTVUTmhMMmVhLVA1MWlqbURDakhBcGtEYThOYzZHV0JkUmVxeXBtdFdvRmhnZHRXZHhDZG51LXQyWG0yTE01VHdwTWhXVDZycEJ0QTRYVXJSczhVd1YxSE9VQ1JrZjIyTnFNZjl2QUk?oc=5","date":"2025-05-29","type":"pipeline","source":"GlobeNewswire","summary":"Vima Therapeutics Launches to Advance the First Oral - GlobeNewswire","headline":"Vima Therapeutics Launches to Advance the First Oral","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPY09vdzg5ajVUN0hDWU9RU1FnR1MyWGlTbnQ3em5McmlRQzZxOTVxbEdpMVdZb0d3a25UWTl4QlJkQXpPdWlOcVZidzFEa185Y2I3WHVqRkg5NS13RDZaN2VWNURqMnRnYWdLMzZ2N1N3ZDV6VnpwV0lWSUZVQm5SZmNxOUtVcGZ0cmg2d2NhOFY5RWFnQ1ZRNkd4Ujlqa0NKU0VNQ1ctNVNqRkdHcUJVc3dhUVVXWHE5eF8zbnlR?oc=5","date":"2019-09-18","type":"pipeline","source":"Fierce Pharma","summary":"Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia - Fierce Pharma","headline":"Merck, Eisai's Keytruda-Lenvima combo wins simultaneous OKs in U.S., Canada and Australia","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}